Search results for "Highlights"


 
Results 151 - 160 of about 465 for "Highlights".
Sort by: Relevance | Newest | Oldest

Pain in diabetes-related polyneuropathy associated with adverse events, death

Patients with type 2 diabetes who had no diabetes-related polyneuropathy, diabetes-related polyneuropathy with pain, and diabetes-related polyneuropathy without pain were compared in an industry-funded retrospective study.
https://diabetes.acponline.org/archives/2020/07/10/3.htm
10 Jul 2020

Hospitalizations for diabetes complications fell, were replaced by other causes

An analysis of excess hospitalizations among people with diabetes in England from 2003 to 2018 found that diabetes caused fewer of their hospital stays, with respiratory disease and cancer becoming more predominant diagnoses.
https://diabetes.acponline.org/archives/2021/12/10/1.htm
10 Dec 2021

Exercise and CBT are cost-effective for diabetes patients with depression

A study used simulation modeling to project the long-term effects of a three-month exercise and cognitive behavioral therapy (CBT) intervention for patients with type 2 diabetes and major depressive disorder. It found clear cost-effectiveness with the interventions alone or combined.
https://diabetes.acponline.org/archives/2021/03/12/3.htm
12 Mar 2021

One-time serum C-peptide testing detected patients misclassified as having type 1 diabetes

In a recent study, a serum C-peptide testing program resulted in reclassification of the cause of diabetes in about 7% of the cohort tested at one diabetes center in Scotland. Reclassification was most likely in those diagnosed at age 30 years or older.
https://diabetes.acponline.org/archives/2020/11/13/2.htm
13 Nov 2020

Adverse events associated with SGLT-2 inhibitors do not appear dose-dependent

In a systematic review and meta-analysis, no difference was seen between high- and low-dose sodium-glucose cotransporter-2 (SGLT-2) inhibitors in overall safety or specific safety outcomes, other than a mild increased risk for adverse events with higher doses of canagliflozin.
https://diabetes.acponline.org/archives/2020/09/11/3.htm
11 Sep 2020

Patients with type 2 diabetes at higher risk for AKI, even without pre-existing kidney disease

The authors of the retrospective study called for additional research on the pathogenesis of acute kidney injury (AKI) and the associated risk factors, such as medications, in diabetic patients.
https://diabetes.acponline.org/archives/2020/10/09/3.htm
9 Oct 2020

Neurologists update guideline on treatment of painful diabetic neuropathy

The updated guideline from the American Academy of Neurology supports offering tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, gabapentinoids, and/or sodium channel blockers to reduce pain from diabetic neuropathy.
https://diabetes.acponline.org/archives/2022/01/14/1.htm
14 Jan 2022

Few diabetes, hypertension patients get recommended testing for kidney disease

Only 21% of patients with diabetes, hypertension, or both underwent urine albumin-to-creatinine ratio testing in a year, despite guideline recommendations, a large recent study found.
https://diabetes.acponline.org/archives/2021/08/13/1.htm
13 Aug 2021

Recent-onset diabetes, weight loss associated with increased pancreatic cancer risk

Unintentional weight loss and weight loss in those with a body mass index already in the normal range were particularly associated with risk of pancreatic cancer among patients with recent-onset diabetes, a study found.
https://diabetes.acponline.org/archives/2020/09/11/2.htm
11 Sep 2020

Spotlight on amputations

Recent studies analyzed data on lower-extremity amputations among patients with diabetes, including recent trends in this complication and its associated mortality, effects of the pandemic, and relationships with diabetes drugs.
https://diabetes.acponline.org/archives/2020/08/14/5.htm
14 Aug 2020

Result Page: Prev   11   12   13   14   15   16   17   18   19   20   Next